SCHEMBL16729555

SCHEMBL16729555

Cc1cc(CNC(C)CO)cc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.45
▸ TRPV3 Q8NET8 3/20 0.41
▸ TMEM97 Q5BJF2 4/20 0.40
▸ KCNH2 Q12809 3/20 0.40
▸ SIGMAR1 Q99720 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ADRA2C P18825 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ DRD3 P35462 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ HTR6 P50406 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ TACR1 P25103 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16727050 0.90 ALDH1A1 (0.50) ALDH1A1TRPV3TMEM97KCNH2SIGMAR1
SCHEMBL18252826 0.85 ALDH1A1 (0.41) ALDH1A1TMEM97KCNH2SIGMAR1LMNA
SCHEMBL16726934 0.84 TRPV3 (0.44) ALDH1A1TRPV3LMNAADRA1AKMT2A
SCHEMBL15587612 0.81 ALDH1A1 (0.38) ALDH1A1TRPV3SIGMAR1HTR1ACYP2D6
SCHEMBL12765145 0.78 NOS1 (0.43) KCNH2HTR2ASLC6A4TACR1IDH1
SCHEMBL13461889 0.76 TACR1 (0.50) MAPTTACR1MTORIDO1
SCHEMBL19443084 0.76 RAPGEF4 (0.41) KCNH2HTR2ASLC6A4TACR1IDH1
SCHEMBL21565748 0.76 TACR1 (0.53) TACR1MTOR
SCHEMBL799344 0.76 RXRA (0.45) MAPTIDH1IDO1
SCHEMBL19689053 0.76 TMEM97 (0.76) ALDH1A1TMEM97KCNH2SIGMAR1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181245-B2 Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease Janssen Pharmaceuticals, Inc. (US) 2015-11-10 — — US disclosed
US-20150141411-A1 SUBSTITUTED 3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-1,6-DIONE DERIVATIVES USEFUL FOR THE TREATMENT OF (INTER ALIA) ALZHEIMER'S DISEASE CELLZOME LIMITED (GB) 2015-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141411-A1 SUBSTITUTED 3,4-DIHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-1,6-DIONE DERIVATIVES USEFUL FOR THE TREATMENT OF (INTER ALIA) ALZHEIMER'S DISEASE BACE1, PSEN1, BACE2 ALDH1A1 693/4885TRPV3 3349/4885TMEM97 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback